% alzhub.org library filter
% Source: https://alzhub.org/research?institution=I2800154431
% 7 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{preische2019-30664784,
  author  = {Preische, O. and Schultz, S. A. and Apel, A. and Kuhle, J. and Kaeser, S. A. and Barro, C. and Gräber, S. and others},
  title   = {{Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease}},
  journal = {Nature medicine},
  year    = {2019},
  doi     = {10.1038/s41591-018-0304-3},
  pmid    = {30664784},
  url     = {https://doi.org/10.1038/s41591-018-0304-3}
}

@article{gibson2020-33074237,
  author  = {Gibson, G. E. and Luchsinger, J. A. and Cirio, R. and Chen, H. and Franchino-Elder, J. and Hirsch, J. A. and Bettendorff, L. and Chen, Z. and others},
  title   = {{Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2020},
  doi     = {10.3233/jad-200896},
  pmid    = {33074237},
  url     = {https://doi.org/10.3233/jad-200896}
}

@article{tariot2018-29955659,
  author  = {Tariot, P. N. and Lopera, F. and Langbaum, J. B. and Thomas, R. G. and Hendrix, S. and Schneider, L. S. and Rios-Romenets, S. and Giraldo, M. and others},
  title   = {{The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer's disease, including a placebo-treated noncarrier cohort}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2018},
  doi     = {10.1016/j.trci.2018.02.002},
  pmid    = {29955659},
  url     = {https://doi.org/10.1016/j.trci.2018.02.002}
}

@article{koronyo2023-36773106,
  author  = {Koronyo, Y. and Rentsendorj, A. and Mirzaei, N. and Regis, G. C. and Sheyn, J. and Shi, H. and Barron, E. and Cook-Wiens, G. and others},
  title   = {{Retinal pathological features and proteome signatures of Alzheimer's disease}},
  journal = {Acta neuropathologica},
  year    = {2023},
  doi     = {10.1007/s00401-023-02548-2},
  pmid    = {36773106},
  url     = {https://doi.org/10.1007/s00401-023-02548-2}
}

@article{zhou2025-41447712,
  author  = {Zhou, Jin and Andreozzi, Erica M. and Llibre‐Guerra, Jorge J. and Clifford, David B. and Li, David and Wang, Guoqiao and Schneider, Lon S. S. and McDade, Eric and others},
  title   = {{Safety of Lecanemab After 6‐Month Treatment in the DIAN‐TU‐001 Trial}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70859_105304},
  pmid    = {41447712},
  url     = {https://doi.org/10.1002/alz70859_105304}
}

@article{llibreguerra2025-41450326,
  author  = {Llibre‐Guerra, Jorge J. and Zhou, Jin and Schneider, Lon S. S. and Andreozzi, Erica M. and Clifford, David B. and Banerjee, Sibabrata and Wang, Guoqiao and McDade, Eric and others},
  title   = {{Baseline Participant Characteristics in the DIAN‐TU‐001 Trial}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70859_105299},
  pmid    = {41450326},
  url     = {https://doi.org/10.1002/alz70859_105299}
}

@article{wassef2022-35543641,
  author  = {Wassef, H. R. and Colletti, P. M.},
  title   = {{Commentary: Aducanumab-Related ARIA: Paean or Lament?}},
  journal = {Clinical nuclear medicine},
  year    = {2022},
  doi     = {10.1097/rlu.0000000000004252},
  pmid    = {35543641},
  url     = {https://doi.org/10.1097/rlu.0000000000004252}
}